Cognitive and motor perturbations in elderly with longstanding diabetes mellitus

Nutrition

Volumn 30, Issue 6, 2014, Pages 628-635

  Diaz Gerevini G T ^a   Repossi, G ^a,b,c   Dain, A ^a   Tarres, M C ^c,d   Das, U N ^e,f   Eynard, A R ^a,c  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b Universidad Nacional de La Rioja   (Argentina)

^c CONICET ^*  (Argentina)

^d FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^e GAYATRI VIDYA PARISHAD COLLEGE OF ENGINEERING   (India)

^f UND Life Sciences   (United States)

Author keywords

DE (Diabetic Encephalopathy); Diabetes mellitus; Dietary lipids; Insulin resistance; Oxidative stress

Indexed keywords

CORTICOSTERONE; DEXAMETHASONE; GLUCOSE TRANSPORTER 4; HYDROCORTISONE; INSULIN RECEPTOR; INSULINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE 2A; POLYUNSATURATED FATTY ACID; PROTEIN KINASE B; INSULIN;

BRAIN CORTEX; BRAIN DISEASE; CELL DIFFERENTIATION; CELL GROWTH; CLINICAL FEATURE; COGNITION; CUSHING SYNDROME; DEMYELINATION; DIABETIC ENCEPHALOPATHY; FAT INTAKE; FOOD QUALITY; GENE DISRUPTION; GENE OVEREXPRESSION; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLYCOSYLATION; HIPPOCAMPUS; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID METABOLISM; MEDICAL LITERATURE; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL ASSESSMENT; OLIGODENDROGLIA; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS REGULATION; REVIEW; SIGNAL TRANSDUCTION; VASCULAR DISEASE; ANIMAL; BRAIN; COGNITION DISORDERS; COMPLICATION; DIET THERAPY; DISEASE MODEL; METABOLISM; VASCULAR DISEASES;

ANIMALS; BRAIN; COGNITION; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HUMANS; INSULIN; VASCULAR DISEASES;

EID: 84899761177     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.11.007     Document Type: Review

References (118)

1. Schoolwerth A.C., Engelgau M.M., Rufo K.H., Vinicor F., Hostetter T.H., Chianchiano D., et al. Chronic kidney disease: a public health problem that needs a public health action plan. Prev Chronic Dis 2006, 3:A57.
2. Schoolwerth A.C., Engelgau M.M., Hostetter T.H. A public health action planis needed for chronic kidney disease. Adv Chronic Kidney Dis 2005, 12:418-423.
3. Biessels G.J., Van Der Heide L.P., Kamal A., Bleys R.L.A.W., Gispen W.H. Ageing and diabetes: implications for brain function. Eur J Pharmacol 2002, 441:1-14.
4. Biessels G.J., Luchsinger J.A. Diabetes and the brain 2009, Humana Press, New York, NY.
5. Korf E.S.C., White L.R., Scheltens P., Launer L.J. Brain aging in very old men with type 2 diabetes: the Honolulu-Asia Aging Study. Diabetes Care 2006, 29:2268-2274.
6. Korf E.S.C., Wahlund L.-O., Visser P.J., Scheltens P. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 2004, 63:94-100.
7. Hong M., Lee V.M. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 1997, 272:19547-19553.
8. Kim B., Backus C., Oh S., Feldman E.L. Hyperglycemia-induced Tau cleavage invitro and invivo: a possible link between diabetes and Alzheimer's disease. J Alzheimer Dis 2013, 34:727-739.
9. Kim B., Backus C., Oh S., Hayes J.M., Feldman E.L. Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. Endocrinology 2009, 150:5294-5301.
10. Edbauer D., Willem M., Lammich S., Steiner H., Haass C. Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD). J Biol Chem 2002, 277:13389-13393.
11. Qiu W.Q., Walsh D.M., Ye Z., Vekrellis K., Zhang J., Podlisny M.B., et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 1998, 273:32730-32738.
12. Dickson D.W., Sinicropi S., Yen S.H., Ko L.W., Mattiace L.A., Bucala R., et al. Glycation and microglial reaction in lesions of Alzheimer's disease. Neurobiol Aging 1996, 17:733-743.
13. Calegari V.C., Torsoni A.S., Vanzela E.C., Araújo E.P., Morari J., Zoppi C.C., et al. Inflammation of the hypothalamus leads to defective pancreatic islet function. J Biol Chem 2011, 286:12870-12880.
14. Keane D.C., Takahashi H.K., Dhayal S., Morgan N.G., Curi R., Newsholme P. Arachidonic acid actions on functional integrity and attenuation of the negative effects of palmitic acid in a clonal pancreatic β-cell line. Clin Sci (Lond) 2011, 120:195-206.
15. Hernández-Fonseca J.P., Rincón J., Pedreañez A., Viera N., Arcaya J.L., Carrizo E., et al. Structural and ultrastructural analysis of cerebral cortex, cerebellum, and hypothalamus from diabetic rats. Exp Diabetes Res 2009, 2009:329632.
16. Fadel J.R., Jolivalt C.G., Reagan L.P. Food for thought: the role of appetitive peptides in age-related cognitive decline. Ageing Res Rev 2013, 1-13.
17. Wickelgren I. Tracking insulin to the mind. Science 1998, 280:517-519.
18. Havrankova J., Brownstein M., Roth J. Insulin and insulin receptors in rodent brain. Diabetologia 1981, 20:268-273.
19. Alquier T., Leloup C., Lorsignol A., Penicaud L. Translocable glucose transporters in the brain: where are we in 2006?. Diabetes 2006, 55:S131-S138.
20. Woods S.C., Benoit S.C., Clegg D.J. The brain-gut-islet connection. Diabetes 2006, 55:S114-S121.
21. Schwartz M.W., Porte D. Diabetes, obesity and the brain. Science 2005, 307:375-379.
22. Matias I., Gonthier M.P., Orlando P., Martiadis V., De Petrocellis L., Cervino C., et al. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J Clin Endocrinol Metab 2006, 91:3171-3180.
23. Navarro A., Díaz M.P., Muñoz S.E., Lantieri M.J., Eynard A.R. Characterization of meat consumption and risk of colorectal cancer in Cordoba, Argentina. Nutrition 2003, 19:7-10.
24. Navarro A., Munoz S.E., Lantieri M.J., del Pilar Diaz M., Cristaldo P.E., de Fabro S.P., et al. Meat cooking habits and risk of colorectal cancer in Cordoba, Argentina. Nutrition 2004, 20:873-877.
25. Andreatta M.M., Navarro A., Munoz S.E., Aballay L., Eynard A.R. Dietary patterns and food groups are linked to the risk of urinary tract tumors in Argentina. Eur J Cancer Prev 2010, 19:478-484.
26. Niclis C., Diaz Mdel P., Eynard A.R., Roman M.D., La Vecchia C. Dietary habits and prostate cancer prevention: a review of observational studies by focusing on South America. Nutr Cancer 2012, 64:23-33.
27. Aballay L.R., Eynard A.R., Díaz M.D.P., Navarro A., Muñoz S.E. Overweight andobesity: a review of their relationship to metabolic syndrome, cardiovascular disease, and cancer in South America. Nutr Rev 2013, 71:168-179.
28. Eynard A.R., Navarro A. Crosstalk among dietary polyunsaturated fatty acids, urolithiasis, chronic inflammation, and urinary tract tumor risk. Nutrition 2013, 29:930-938.
29. Holt T.A., Kumar S., Watkins P.J. ABC of diabetes 2010, Wiley-Blackwell/BMJ Books, Chichester, West Sussex, UK; Hoboken, NJ. 6th ed.
30. Lee H.K., Kumar P., Fu Q., Rosen K.M., Querfurth H.W. The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid. Mol Biol Cell 2009, 20:1533-1544.
31. Liu Y., Hong X., Kappler J., Jiang L., Zhang R., Xu L., et al. Ligand-receptor binding revealed by the TNF family member TALL-1. Nature 2003, 423:49-56.
32. Zhao W., Chen H., Xu H., Moore E., Meiri N., Quon M.J., et al. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J Biol Chem 1999, 274:34893-34902.
33. Meyts P De, Whittaker J. Structural biology of insulin and IGF1 receptors: implications for drug design. Nat Rev Drug Discov 2002, 1:769-783.
34. Hubbard S.R., Wei L., Ellis L., Hendrickson W.A. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 1994, 372:746-754.
35. McEwen B.S., Reagan L.P. Glucose transporter expression in the central nervous system: relationship to synaptic function. Eur J Pharmacol 2004, 490:13-24.
36. Vargas R., Rincón J., Pedreañez A., Viera N., Hernández-Fonseca J.P., Peña C., et al. Role of angiotensin II in the brain inflammatory events during experimental diabetes in rats. Brain Res 2012, 1453:64-76.
37. Shimoji K., Abe O., Uka T., Yasmin H., Kamagata K., Asahi K., et al. White matter alteration in metabolic syndrome: diffusion tensor analysis. Diabetes Care 2013, 36:696-700.
38. Reijmer Y.D., Leemans A., Brundel M., Kappelle L.J., Biessels G.J. Disruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetes. Diabetes 2013, 1-20.
39. Reijmer Y.D., Brundel M., De Bresser J., Kappelle L.J., Leemans A., Biessels G.J. Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging study. Diabetes Care 2012.
40. Das U.N. Is type 2 diabetes mellitus a disorder of the brain?. Nutrition 2002, 18:667-672.
41. Daniele S.M., Arriaga S., Martínez S.M., Tarrés M.C., Montenegro S.M., D'Ottavio A.E., et al. Onset and evolution of nephropathy in rats with spontaneous diabetes mellitus. J Physiol Biochem 2000, 56:45-53.
42. Tarrés M.C., Martinez S.M., Montenegro S., Llorens A., Picena J.C., Naves A. The eSS rat. A model of non-insulin-dependent human diabetes. Amer J Pathol 1992, 141:761-763.
43. Sperandio S., Poksay K., De Belle I., Lafuente M.J., Liu B., Nasir J., et al. Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix. Cell Death Differ 2004, 11:1066-1075.
44. Sperandio S., De Belle I., Bredesen D.E. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci U S A 2000, 97:14376-14381.
45. Kodl C.T., Seaquist E.R. Cognitive dysfunction and diabetes mellitus. Endocr Rev 2008, 29:494-511.
46. Wysocki T., Harris M.A., Mauras N., Fox L., Taylor A., Jackson S.C., et al. Absence of adverse effects of severe hypoglycemia on cognitive function in school-aged children with diabetes over 18 months. Diabetes Care 2003, 26:1100-1105.
47. Hershey T., Perantie D.C., Wu J., Weaver P.M., Black K.J., White N.H. Hippocampal volumes in youth with type 1 diabetes. Diabetes 2010, 59:236-241.
48. The effect of intensive treatment of diabetes on development and progression of long term complications in insulin dependent diabetes melitus. N Engl J Med 1993, 329:977-986. The Diabetes Control and Complications Trial.
49. Lee B.-W., Jin E.S., Hwang H.-S., Yoo H.-J., Jeong J.H. A case of hypoglycemic brain injuries with cortical laminar necrosis. J Korean Med Sci 2010, 25:961-965.
50. Auer R.N. Hypoglycemic brain damage. Forensic Sci Int 2004, 146:169-175.
51. Hudson B.I., Hofmann M.A., Bucciarelli L., Wendt T., Moser B., Lu Y., et al. Glycation and diabetes: the RAGE connection. Curr Sci 2002, 83:1515-1521.
52. Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. JClin Invest 2001, 108:949-955.
53. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54:1615-1625.
54. Klein J.P., Waxman S.G. The brain in diabetes: molecular changes in neurons and their implications for end-organ damage. Lancet 2003, 2:548-554.
55. Skeberdis V.A., Lan J., Zheng X., Zukin R.S., Bennett M.V.L. Insulin promotes rapid delivery of N-methyl-D-aspartate receptors to the cell surface by exocytosis. Proc Natl Acad Sci U S A 2001, 98:3561-3566.
56. Brownlee M., Hirsch I.B. Glycemic variability: a hemoglobin A1 c-independent risk factor for diabetic complications. JAMA 2006, 295:1707-1708.
57. Exalto L.G., Whitmer R.A., Kappele L.J., Biessels G.J. An update on type 2diabetes, vascular dementia and Alzheimer's disease. Exp Gerontol 2012, 47:858-864.
58. Medicina F De, Coimbra U De Disfunção Endotelial na Diabetes Tipo 2: introduction. Rev Port Cardiol 2007, 26:609-619.
59. Bloomgarden Z.T. Cardiovascular disease in diabetes. Diabetes Care 2002, 1:313-318.
60. Banks W.A., Owen J.B., Erickson M.A. Insulin in the brain: there and back again. Pharmacol Therap 2012, 136.
61. Das U.N., Repossi G., Dain A., Eynard A.R. Is insulin resistance a disorder of the brain?. Front Biosci 2011, 16:1-12.
62. Bingham E.M., Hopkins D., Smith D., Pernet A., Hallett W., Reed L., et al. The role of insulin in human brain glucose metabolism: an 18 fluoro-deoxyglucose positron emission tomography dtudy. Diabetes 2002, 51:3384-3390.
63. Reger M.A., Watson G.S., Green P.S., Baker L.D., Cholerton B., Fishel M.A., et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. JAlzheimers Dis 2008, 13:323-331.
64. Maher P.A., Schubert D.R. Metabolic links between diabetes and Alzheimer's disease. Expert Rev Neurother 2009, 9:617-630.
65. Reger M.A., Watson G.S., Frey W.H., Baker L.D., Cholerton B., Keeling M.L., et al. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging 2006, 27:451-458.
66. Nielson K.A., Nolan J.H., Berchtold N.C., Sandman C.A., Mulnard R.A., Cotman C.W. Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease?. J Am Geriatr Soc 1996, 44:897-904.
67. Takeda S., Sato N., Uchio-Yamada K., Sawada K., Kunieda T., Takeuchi D., et al. Elevation of plasma beta-amyloid level by glucose loading in Alzheimer mouse models. Biochem Biophys Res Comm 2009, 385:193-197.
68. Takeda S., Sato N., Uchio-Yamada K., Sawada K., Kunieda T., Takeuchi D., et al. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci U S A 2010, 107:7036-7041.
69. S Roriz-Filho J, Sá-Roriz T.M., Rosset I., Camozzato A.L., Santos A.C., Chaves M.L.F., et al. (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta 2009, 1792:432-443.
70. Prpić-Križevac I., Canecki-Varžić S., Bilić-Ćurčić I. Hyperactivity of the hypothalamic-pituitary-adrenal axis in patients with type 2 diabetes and relations with insulin resistance and chronic complications. Wien Klin Wochenschr 2012, 124:403-411.
71. Ott A., Stolk R.P., Hofman A., Van Harskamp F., Grobbee D.E., Breteler M.M. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 1996, 39:1392-1397.
72. Brown E.S., Rush A.J., McEwen B.S. Hippocampal remodeling and damagebycorticosteroids: implications for mood disorders. Neuropsychopharmacology 1999, 21:474-484.
73. Newcomer J.W., Selke G., Melson A.K., Hershey T., Craft S., Richards K., et al. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry 1999, 56:527-533.
74. Heffelfinger A.K., Newcomer J.W. Glucocorticoid effects on memory function over the human life span. Dev Psychopathol 2001, 13:491-513.
75. Okin D., Medzhitov R. Evolution of inflammatory diseases. Curr Biol CB 2012, 22:R733-R740.
76. Ziegler D. Type 2 diabetes as an inflammatory cardiovascular disorder. Curr Mol Med 2005, 5:309-322.
77. Sima A.A.F., Zhang W., Kreipke C.W., Rafols J.A., Hoffman W.H. Inflammation in diabetic encephalopathy is prevented by C-peptide. Rev Diabet Stud 2009, 6:37-42.
78. Trovati M., Massucco P., Anfossi G., Cavalot F., Mularoni E., Mattiello L., et al. Insulin influences the renin-angiotensin-aldosterone system in humans. Metabol Clin Experim 1989, 38:501-503.
79. Perkins J.M., Davis S.N. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control. Curr Opin Endocrinol Diabetes Obes 2008, 15:147-152.
80. Nguyen D.V., Shaw L.C., Grant M.B. Inflammation in the pathogenesis of microvascular complications in diabetes. Front Endocrinol (Lausanne) 2012, 3:170.
81. Perry V.H., Nicoll J.A.R., Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol 2010, 6:193-201.
82. Amor S., Puentes F., Baker D., Van Der Valk P. Inflammation in neurodegenerative diseases. Immunology 2010, 129:154-169.
83. Coste T.C., Gerbi A., Vague P., Pieroni G., Raccah D. Neuroprotective effect of docosahexaenoic acid-enriched phospholipids in experimental diabetic neuropathy. Diabetes 2003, 52:2578-2585.
84. Frisardi V., Solfrizzi V., Seripa D., Capurso C., Santamato A., Sancarlo D., et al. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. J Neural Transm 2010, 9:371-379.
85. Varma V., Yao-Borengasser A., Rasouli N., Nolen G.T., Phanavanh B., Starks T., et al. Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Amer J Physiol Endocrin Metabol 2009, 296:E1300-E1310.
86. Bunn R.C., Cockrell G.E., Ou Y., Thrailkill K.M., Lumpkin C.K., Fowlkes J.L. Palmitate and insulin synergistically induce IL-6 expression in human monocytes. Cardiov Diabetol 2010, 9:73.
87. Eynard A.R. Is the risk of urinary tract tumorigenesis enhanced by a marginal chronic essential fatty acid deficiency (EFAD)?. Nutrition 1998, 14:211-216.
88. Miners J.S., Baig S., Palmer J., Palmer L.E., Kehoe P.G., Love S. Abeta-degrading enzymes in Alzheimer's disease. Brain Pathol 2008, 18:240-252.
89. Park J.Y., Kim M.J., Kim Y.K., Woo J.S. Ceramide induces apoptosis via caspase-dependent and caspase-independent pathways in mesenchymal stem cells derived from human adipose tissue. Arch Toxicol 2011, 85:1057-1065.
90. Movsesyan V.A., Yakovlev A.G., Dabaghyan E.A., Stoica B.A., Faden A.I. Ceramide induces neuronal apoptosis through the caspase-9/caspase-3 pathway. Biochem Biophys Res 2002, 299:201-207.
91. Zhao L.X., Teter B., Morihara T., Lim G.P., Ambegaokar S.S., Ubeda O.J., et al. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade. J Neurosci 2004, 24:11120-11126.
92. Liu Y., Liu F., Grundke-Iqbal I., Iqbal K., Gong C.-X. Deficient brain insulin signaling pathway in Alzheimer's disease and diabetes. J Pathol 2011, 225:54-62.
93. Qu Z., Jiao Z., Sun X., Zhao Y., Ren J., Xu G. Effects of streptozotocin-induced diabetes on tau phosphorylation in the rat brain. Brain Res 2011, 1383:300-306.
94. Ling Y., Morgan K., Kalsheker N. Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease. Internat J Biochem Cell Biol 2003, 35:1505-1535.
95. Farris W., Mansourian S., Chang Y., Lindsley L., Eckman E.A., Frosch M.P., et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain invivo. Proc Natl Acad Sci U S A 2003, 100:4162-4167.
96. Müllner E., Brath H., Pleifer S., Schiermayr C., Baierl A., Wallner M., et al. Vegetables and PUFA-rich plant oil reduce DNA strand breaks in individuals with type 2 diabetes. Mol Nutr Food Res 2013, 57:328-338.
97. Kamboj S.S., Sandhir R. Protective effect of N-acetylcysteine supplementation on mitochondrial oxidative stress and mitochondrial enzymes in cerebral cortex of streptozotocin-treated diabetic rats. Mitochondrion 2011, 11:214-222.
98. Lu M., Xu L., Li B., Zhang W., Zhang C., Feng H., et al. Protective effects of grape seed proanthocyanidin extracts on cerebral cortex of streptozotocin-induced diabetic rats through modulating AGEs/RAGE/NF-kappaB pathway. J Nutr Sci Vitam 2010, 56:87-97.
99. Lakshmanan A.P., Watanabe K., Thandavarayan R.A., Sari F.R., Meilei H., Soetikno V., et al. Curcumin attenuates hyperglycaemia-mediated AMPK activation and oxidative stress in cerebrum of streptozotocin-induced diabetic rat. Free Radic Res 2011, 45:788-795.
100. Yaffe K., Blackwell T., Whitmer R.A., Krueger K., Barrett Connor E. Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women. J Nutr Health Aging 2006, 10:293-295.
101. Sinclair A.J., Girling A.J., Bayer A.J. Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. Diabetes Res Clin Pract 2000, 50:203-212.
102. Bergman R.N., Pacini G., Porte D. Pathogenesis of age-related glucose intolerance in man: Insulin resistance and decreased-cell function. J Clin Endocrin Metab 1985, 60:13-20.
103. Parker G., Gibson N.A., Brotchie H., Heruc G., Rees A.-M., Hadzi-Pavlovic D. Omega-3 fatty acids and mood disorders. Am J Psychiatry 2006, 163:969-978.
104. Espeland M.A., Miller M.E., Goveas J.S., Hogan P.E., Coker L.H., Williamson J., et al. Cognitive function and fine motor speed in older women with diabetes mellitus: results from the women's health initiative study of cognitive aging 1937. J Womens Health 2011, 20:1435-1443.
105. Vermeer S.E., Den Heijer T., Koudstaal P.J., Oudkerk M., Hofman A., Breteler M.M.B. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2002, 33:21-25.
106. Manschot S.M., Biessels G.J., De Valk H., Algra A., Rutten G.E.H.M., Van Der Grond J., et al. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 2007, 50:2388-2397.
107. Scheltens P., Barkhof F., Leys D., Pruvo J.P., Nauta J.J., Vermersch P., et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993, 114:7-12.
108. Xu L., Li B., Cheng M., Zhang W., Pan J., Zhang C., et al. Oral administration ofgrape seed proanthocyanidin extracts downregulate RAGE dependantnuclear factor-kappa BP65 expression in the hippocampus of streptozotocin induced diabetic rats. Exp Clin Endocrinol Diabetes 2008, 116:215-224.
109. Suryanarayana P., Satyanarayana A., Balakrishna N., Kumar P.U., Reddy G.B. Effect of turmeric and curcumin on oxidative stress and antioxidant enzymes in streptozotocin-induced diabetic rat. Med Sci Monit 2007, 13:BR286-BR292.
110. Munoz S.F., Silva R.A., Lamarque A., Guzman C.A., Eynard A.R. Protective capability of dietary Zizyphus mistol seed oil, rich in 18:3, n-3, on the development of two murine mammary gland adenocarcinomas with high or low metastatic potential. Prostaglandins Leukot Essent 1995, 53:135-138.
111. Lankinen M., Schwab U., Erkkilä A., Seppänen-Laakso T., Hannila M.-L., Mussalo H., et al. Fatty fish intake decreases lipids related to inflammation and insulin signaling-a lipidomics approach. PLoS One 2009, 4:9.
112. Das U.N. Can essential fatty acids reduce the burden of disease(s)?. Lipids Health Dis 2008, 7:9.
113. Lu D.-Y., Tsao Y.-Y., Leung Y.-M., Su K.-P. Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: Implications of antidepressant effects for ω-3 fatty acids. Neuropsychopharmacology 2010, 35:2238-2248.
114. Lim W.S., Gammack J.K., Van Niekerk J., Dangour A.D. Omega 3 fatty acid for the prevention of dementia. Cochrane Database 2006, CD005379. 10.1002/14651858.CD005379.pub2.
115. Oster T., Pillot T. Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice. Biochim Biophys Acta 2010, 1801:791-798.
116. Das U.N. Metabolic syndrome pathophysiology: the role of essential fatty acids 2010, Wiley-Blackwell, Ames, IA.
117. Yang R.-H., Wang F., Hou X.-H., Cao Z.-P., Wang B., Xu X.-N., et al. Dietary Omega-3 Polyunsaturated fatty acids improves learning performance of diabetic rats by regulating the neuron excitability. Neuroscience 2012, 212:93-103.
118. Zhao C.H., Liu H.Q., Cao R., Ji A.L., Zhang L., Wang F., Yang R.H. Effects of dietary fish oil on learning function and apoptosis of hippocampal pyramidal neurons in streptozotocin-diabetic rats. Brain Res 2012, 457:33-43.